Evidence map›Paper›PMID 37256061›Full record

ArticleFrontiers in microbiology2023

Egg yolk antibody combined with bismuth-based quadruple therapy in

Sha Cheng, Huan Li, Ju Luo, Jingshu Chi, Wenfang Zhao, Jiahui Lin, Canxia Xu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Efficacy of IgY onAntibody therapeutics · 2026
    Article
  2. Beyond Antibiotics: Alternative Strategies TargetingExpert reviews in molecular medicine · 2026
    Review
  3. Progress in immunotherapy forFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sha Cheng *Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Huan Li *Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Ju LuoDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Jingshu ChiDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Wenfang ZhaoDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Jiahui LinDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Canxia XuDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
Third Xiangya Hospital · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The increasing antibiotic resistance is the main issue causing Methods: In this randomized, controlled study, 100 Results: The Conclusion: Both groups achieved satisfactory eradication efficiency in

Indexed as

bismuth-based quadruple therapyegg yolk antibody (Ig Y)Helicobacter pyloriIg Y-H. pylorirescue therapy

Identifiers

PMID37256061
PMCPMC10225724
OpenAlexW4376570373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.